CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...